Search

everythinglearnresearchcommunity

for

Search:↓

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

Agomelatine may help reduce benign prostatic hyperplasia by blocking certain inflammatory pathways.

Adding celecoxib to chemotherapy improves survival and quality of life for gastric cancer patients with positive COX-2.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

A cystic fibrosis patient developed Cushing's syndrome from a drug interaction between itraconazole and budesonide, which improved after stopping the medications.

Tofacitinib might be used to treat hair loss.

Botulinum toxin type A helps treat hair loss by stopping cell death in hair follicles through a process involving certain non-coding RNAs and a protein called Bax.

A new compound with strong antiandrogenic effects was found, potentially useful for treating conditions like acne and prostate cancer.

Stress increases neurosteroids that help prevent seizures.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

D-004 shows moderate antidepressant effects but is less effective than Sertraline and Imipramine.

Birth control pills increase certain receptor activities in female gerbil prostate glands and can lead to prostate changes.

Sinapic acid and glabridin together help hair growth in androgenetic alopecia.

Fish oil increased cell growth and macrophages in the skin but didn't affect COX-2 expression.

Some drugs may increase the risk of obstructive sleep apnea, while others like certain biologics might decrease it.

Cyproterone acetate effectively treats sexual disorders by reducing sexual functions and is generally well-tolerated.

Chronic ethanol increases certain brain receptor levels, influenced by steroids and protein changes.

Dienogest is safer and has fewer side effects than GnRH analogues for treating endometriosis.

Budesonide is not effective for maintaining remission in Crohn's disease beyond three months.

A compound named ZCZ90 can increase muscle spindle firing, potentially helping treat muscle spasms and hypertension.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.

Finasteride blocks deoxycorticosterone's anticonvulsant effects in infant rats, but indomethacin doesn't.

A new hair loss treatment combining minoxidil and cedrol improves hair growth and reduces side effects.

Monitoring for adverse effects in clinical treatments is crucial.

Oncology specialists are disappointed by the discontinuation of the effective lymphoma treatment Bexxar.

Agmatine may help reduce seizures linked to hormone changes in female rats.